As the primary health care decision maker for most families, women have an important role to play in making sure all medicines are safe to use for themselves and their families.
In the United States, medicine safety is largely overseen by the Food and Drug Administration (FDA), which approves the sale and marketing of prescription and over-the-counter medicines. However, FDA approval is not enough. Medication that is expired, damaged, adulterated or even fraudulent are also important concerns.
The best way to make sure that your medicines are not adulterated or fraudulent is to purchase them from reliable sources. While most major pharmacy chains now have mail order (or phone or internet) options, pharmacies that are based only on the Internet should be viewed cautiously.
First, it can be very difficult (if not impossible) to know where these pharmacies are located and where the medicines they will be sending you came from. Second, medicine “trans-shipped” from one country through another to the U.S. may appear to come from that intermediary country, but could be fake or somehow substandard and not meet that country’s standards. Third, medicines shipped from other countries can be confiscated at the border since importation of most medicines is not legal in the U.S (although you can generally bring small quantities for personal use when traveling). HealthyWomen has expressed our general and specific safety concerns about the importation of medicines to policy-makers. For example, see the letter we sent (along with others) to State Senators in Colorado.
Such aspects of buying medicines online from outside the U.S. are ongoing important policy issues about which HealthyWomen will continue to monitor and provide information.
Another area of concern with purchasing medicines from other countries is that patients lose the ability to communicate with their pharmacist about their medicines. Your local pharmacist — or one you can call at your mail order pharmacy — can be an important source of information as part of your care team. Lastly, medicines purchased from other countries are not covered by any insurance benefits, including applying their cost towards your deductible. As part of our medication safety policy work, we will continue to advocate for better care coordination and communications among patients and clinicians.
In the news
Are dietary supplements safe and effective? This professor of pharmacy explains what consumers should consider. share
Vaping and e-cigarettes have become an epidemic. This is a serious public health and women’s health problem because many adolescents and young people have started vaping recently, and vaping is now associated with deaths and of severe lung injuries. share
Biosimilars are powerful, life-changing medicines. Many chronic, debilitating autoimmune diseases that affect women in greater numbers than men, such as lupus and rheumatoid arthritis, can now be treated with biosimilars, as can breast cancer. share
Importation of prescription drugs to lower costs is being proposed by the Trump Administration using demonstration projects and other pathways. Safety concerns and monitoring have yet to be addressed, but it could be human experimentation without informed share
Over the counter drugs and supplements may contain dangerous toxins or unapproved drug ingredients, so people who take them may be risking serious health problems. share
Despite growing concerns about creating drug-resistant bacteria, overprescribing of antibiotics in U.S. hospitals didn't drop between 2006 and 2012, according to a new federal report. share
Products with CBD (cannabidiol) are being widely sold, but there are unknown risks to the health of women, breast-feeding infants, or a developing fetus. share
New Poll Shows Women Interested in Medication Quality, Cost of Health Care, and Issues in International Trade
A new poll shows that women voters are concerned about PBMs driving up health care costs for women and families - and are also concerned about the quality of medicines made outside the U.S., and other countries stealing US companies’ intellectual property share